Technical Trend Overview and Price Movement
Fortis Healthcare’s price action has been relatively stable in the short term, with the stock trading within a range between ₹915.65 and ₹938.35 today. The 52-week high stands at ₹1,105.00, while the 52-week low is ₹701.05, indicating a significant recovery over the past year. The shift from a mildly bearish to a sideways technical trend suggests a consolidation phase, where the stock is neither strongly trending upwards nor downwards, reflecting indecision among traders.
Daily moving averages remain mildly bearish, signalling some short-term caution. However, weekly and monthly indicators provide a more nuanced view, with several oscillators and trend-following tools diverging in their signals.
MACD and Momentum Indicators
The Moving Average Convergence Divergence (MACD) indicator shows a bullish signal on the weekly timeframe, indicating upward momentum in the near term. Conversely, the monthly MACD remains mildly bearish, suggesting that the longer-term momentum has yet to fully confirm a sustained uptrend. This divergence between weekly and monthly MACD readings highlights a transitional phase where short-term optimism is tempered by longer-term caution.
The Know Sure Thing (KST) indicator aligns with this mixed picture, showing bullish momentum on the weekly chart but mildly bearish readings monthly. Such conflicting signals often precede a period of sideways price action, as market participants await clearer directional cues.
RSI and Bollinger Bands Analysis
The Relative Strength Index (RSI) currently provides no definitive signal on either the weekly or monthly charts, hovering in neutral territory. This lack of overbought or oversold conditions supports the sideways trend narrative, indicating that the stock is not currently stretched in either direction.
Bollinger Bands, however, are bullish on both weekly and monthly timeframes. The stock price is trading near the upper band on these charts, suggesting increased volatility and a potential for upward breakout if momentum sustains. This bullish band positioning contrasts with the neutral RSI, underscoring the mixed technical environment.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Volume and Dow Theory Signals
On-Balance Volume (OBV) indicators show no clear trend on either weekly or monthly charts, suggesting that volume is not currently confirming price movements. This absence of volume confirmation often accompanies sideways price action and can signal a lack of conviction among traders.
Dow Theory assessments are mildly bearish on the weekly timeframe but mildly bullish monthly, reinforcing the theme of mixed signals. The weekly bearishness may reflect short-term profit-taking or consolidation, while the monthly bullishness points to a more positive medium-term outlook.
Comparative Returns and Market Context
Fortis Healthcare’s stock has delivered impressive returns over multiple time horizons, significantly outperforming the Sensex. Year-to-date, the stock has gained 5.27%, while the Sensex has declined by 12.76%. Over one year, Fortis surged 27.66% compared to the Sensex’s 7.92% loss. The three-year and five-year returns are even more striking, with Fortis up 236.81% and 309.19% respectively, dwarfing the Sensex’s 18.86% and 42.34% gains. Over a decade, Fortis has appreciated by 481.86%, more than doubling the Sensex’s 176.97% rise.
These figures underscore the stock’s strong fundamental and market performance, despite the current technical consolidation phase. Investors should weigh these long-term gains against the present technical signals when considering new positions or portfolio adjustments.
Mojo Score and Rating Update
MarketsMOJO assigns Fortis Healthcare a Mojo Score of 44.0, reflecting a cautious stance. The Mojo Grade was downgraded from Hold to Sell on 1 June 2026, signalling increased risk or deteriorating technical/fundamental conditions. This downgrade aligns with the mildly bearish daily moving averages and mixed monthly technical indicators, suggesting investors should exercise prudence.
As a mid-cap hospital sector stock, Fortis faces sector-specific challenges and opportunities, including regulatory changes, healthcare demand fluctuations, and competitive pressures. The current technical signals imply a wait-and-watch approach may be prudent until clearer momentum emerges.
Fortis Healthcare Ltd or something better? Our SwitchER feature analyzes this mid-cap Hospital stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Investor Takeaway and Outlook
Fortis Healthcare’s technical landscape is characterised by a transition from bearishness to sideways consolidation, with weekly momentum indicators showing tentative bullishness while monthly signals remain cautious. The stock’s current price near ₹930, just above the previous close of ₹929.50, reflects this equilibrium.
Investors should note the divergence between short-term bullish MACD and Bollinger Bands against mildly bearish moving averages and Dow Theory signals. The neutral RSI and lack of volume trend confirmation further suggest that a decisive directional move may be pending.
Given the strong historical returns relative to the Sensex, long-term investors may view current technical consolidation as a pause before potential further gains. However, the recent downgrade to a Sell rating by MarketsMOJO advises caution, particularly for those seeking momentum-driven trades.
In summary, Fortis Healthcare is at a technical crossroads. A break above the recent high of ₹938.35 with volume confirmation could signal renewed upward momentum, while a failure to hold support near ₹915 may lead to further consolidation or downside risk. Monitoring weekly MACD and Bollinger Bands alongside moving averages will be critical for timely investment decisions.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
